---
title: "Top Midday Decliners"
date: "2025-02-11 02:46:38"
summary: "Pliant Therapeutics sank after midday Monday after the company's shares were the subject of several rating downgrades following a Pliant announcement late Friday that it suspended enrollment and dosing in a phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis. Shares slumped nearly 59% following a surge in intraday trading..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Pliant Therapeutics sank after midday Monday after the company's shares were the subject of several rating downgrades following a Pliant announcement late Friday that it suspended enrollment and dosing in a phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis.

Shares slumped nearly 59% following a surge in intraday trading volume to over 14.1 million from a daily average of about 630,000.

B. Riley adjusted its price target for Semtech's shares to $68 from $85 while keeping the buy rating.

Shares of Semtech dropped 30% as intraday trading volume rose to over 13.7 million from the stock's daily average of about 2.1 million.

Hain Celestial Group said Monday it is exploring strategic options for its personal care business as it shifts focus to its better-for-you food and beverages portfolio.

Shares retreated 14% as intraday trading volume surged to more than 2.8 million from a daily average of roughly 1.5 million.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:A3313793:0/)
